Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

bladder transitional cell carcinoma - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

bladder transitional cell carcinoma

MONDO:0005611

Also known as:bladder urothelial cancerbladder urothelial carcinomatransitional cell carcinoma of bladder

Find Clinical TrialsTrials

Overview

The most common morphologic subtype of urinary bladder carcinoma (over 90% of cases). It arises from the transitional epithelium. It most often affects males in their sixth and seventh decades of life. Hematuria is the most common symptom at presentation. Pathologic stage is the strongest predictor of survival.

Clinical Trials76 registered · 19 recruiting

Diagnosis

Biomarker and diagnostic research for bladder transitional cell carcinoma has been reported in the published literature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

76 clinical trials registered, 19 recruiting. Interventions under study include drug therapy, procedural interventions, other interventions, and biologic therapy. Pipeline includes 2 PHASE4, 11 PHASE3, 26 PHASE2. Research is sponsored by a mix of industry and academic institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT04878029](https://clinicaltrials.gov/study/NCT04878029)

Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:00 AM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

Questions for Your Care Team

→Are any of the 76 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Laboratory research	51	34%
Testing and diagnosis research	39	26%
Disease patterns and progression	21	14%
Clinical study results	13	9%
Patient case studies	12	8%
Research summaries	10	7%
Other research	3	2%
New treatment approaches	1	1%

bladder transitional cell carcinoma

Overview

Diagnosis

Research Landscape

Medical References

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications